RAJNISH KUMAR
Associate Professor · Noida Institute of Engineering and Technology (Pharmacy Institute), Greater Noida
Research Interests
Strong integration of teaching, research, and scientific communication. My teaching area centers on pharmaceutical chemistry, organic chemistry, and biomedical sciences. On the research front, his work spans heterocyclic chemistry, medicinal chemistry, and dru...
Biography
Dr. Rajnish Kumar is a distinguished academic researcher, educator, and scientific communicator in pharmaceutical chemistry, organic chemistry, and biomedical sciences, with affiliations at the Noida Institute of Engineering and Technology (Pharmacy Institute) and Shri Ram Murti Smarak College of Engineering, Technology & Research. His scholarly presence is widely recognized across platforms including Google Scholar, Web of Science, Scopus, ResearchGate, LinkedIn, and ORCID, where he has authored over 120 publications, accumulated more than 1,000 citations, and achieved an h-index of 17. His research focuses on heterocyclic chemistry, medicinal chemistry, and drug design, particularly exploring benzimidazoles, oxadiazoles, quinolines, pyrazolines, and piperazine derivatives for therapeutic applications such as anticancer, anticonvulsant, anti-inflammatory, and anti-diabetic agents. Collectively, his academic footprint positions him as a thought leader in medicinal chemistry.
Education
Ph. D. in Pharmaceutical Science. M Pharm (Pharmaceutical Chemistry)
Recent Scopus Publications
- Synthesis, in-vivo, ADMET prediction, molecular docking studies, MD simulation, and DFT analysis of novel 1,3,4-oxadiazole-furan hybrids as anticonvulsants
- Comment on “S, N, P, and B-doped bio-carbons as dual catalysts for tetracycline degradation via the heterogeneous electro-Fenton process”
- Re: Furrer MA, Lyttwin B, Pärli MS, et al. Incidental Prostate Cancer Is an Uncommon but Clinically Nonnegligible Cause of Death in Selected Long-term Survivors of Urothelial Carcinoma—Oncological Outcomes and a Proposed Follow-up Strategy from a Tertiary Referral Center. Eur Urol Open Sci 2026;86:10–9
- An Insight into the Structural Modification and Mechanism of Ursolic Acid at C-3 and C-28: Strategy for Searching Anti-Cancer Therapeutics
- Advances in the Synthesis and Therapeutic Exploration of Pyrazole/Pyrazoline- Bearing Benzimidazoles: Searching for New Lead Compounds
Research Outputs
Anticonvulsant Potential of Novel Pyrazoline Derivatives Containing Benzothiazole Moiety.
Links
- ORCID https://orcid.org/0000-0001-7479-696X
- Google Scholar https://scholar.google.com/citations?user=sxLj4_4AAAAJ
- Scopus https://www.scopus.com/authid/detail.uri?authorId=57845367400